AKT1 and Insulin resistance: A prior study on Gpx KO mice revealed that Gpx1 deficiency enhances insulin signaling in vivo by the inhibition of PTEN, a negative modulator of the PI3K/Akt pathway, to attenuate the development of insulin resistance (19).